Clinical Trials Browser

Phase 2 × INDUSTRY × GDC-0084 × Clear all

NCT03522298 2025-03-24

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Phase 2 Completed

30 enrolled 27 charts

Glioblastoma